FDA Inspection 834831 — Newborn Blood Banking, Inc.
The FDA completed an inspection of Newborn Blood Banking, Inc. on June 11, 2013 in Land O Lakes, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 11, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Land O Lakes, FL (United States)